Pure Global

Sweat Analysis as Prognosticator After Heart Attack - Trial NCT05843006

Access comprehensive clinical trial information for NCT05843006 through Pure Global AI's free database. This phase not specified trial is sponsored by Region ร–rebro County and is currently Completed. The study focuses on Acute Myocardial Infarction. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05843006
Completed
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT05843006
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Sweat Analysis as Prognosticator After Heart Attack
SWEAT Analysis for Predicting Patient Outcome After HEART Attack

Study Focus

Examination and analysis of sweat and blood samples at baseline and at follow up

Observational

diagnostic test

Sponsor & Location

Region ร–rebro County

ร–rebro, Sweden

Timeline & Enrollment

N/A

Mar 21, 2022

Mar 31, 2023

24 participants

Primary Outcome

Inflammation panels in sweat and blood correlated to clinical outcome

Summary

This study characterizes non-invasive body inflammation response in sweat and blood of
 patients suffering from acute myocardial infarction and explores the potential of
 non-invasive sweat analysis a an innovative approach for predicting patient outcome.

ICD-10 Classifications

Acute myocardial infarction
Acute myocardial infarction, unspecified
Acute subendocardial myocardial infarction
Certain current complications following acute myocardial infarction
Other current complications following acute myocardial infarction

Data Source

ClinicalTrials.gov

NCT05843006

Non-Device Trial